Companies › REPL

REPLIMUNE GROUP INC (REPL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001737953 · EDGAR filings · Updated 2026-07-24

REPLIMUNE GROUP INC (REPL) has reported institutional ownership of 96.6%, with 179 institutional managers holding positions valued at $619.2M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-24 — S-3/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-13 — PRE 14A filed
• 2026-06-29 — Employee-plan registration (S-8) filed
• 2026-06-29 — Annual report (10-K) filed
• 2026-06-29 — Current report (8-K) filed
• 2026-06-26 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, REPLIMUNE GROUP INC has 179 institutional holders and institutional ownership of 96.6%.

Insider activity

Insiders reported 23 transactions (0 buys, 11 sells) across 7 reporting insiders, with a net reported value of −$910.4K.

Data flags from SEC filings

Related companies

AMPHASTAR PHARMACEUTICALS INC COM (AMPH) · ARBUTUS BIOPHARMA CORP (ABUS) · AKTIS ONCOLOGY INC (AKTS) · STEVANATO GROUP S P A (STVN) · XERIS BIOPHARMA HOLDINGS INC (XERS) · OMADA HEALTH INC (OMDA)